Lasting protection against Ebola from single-dose inhaled vaccine looks feasible

Share this content:
Lasting protection against Ebola from single-dose inhaled vaccine looks feasible
Lasting protection against Ebola from single-dose inhaled vaccine looks feasible
In trials with non-human primates, a single inhaled dose of the experimental vaccine, successfully gave the animals long-term protection against lethal Ebola infection. Results of the pre-clinical study are reported in the journal Molecular Pharmaceutics. A vaccine would not only reduce transmission from person to person in an ongoing epidemic, but it would also help control further outbreaks.
READ FULL ARTICLE From Medical News Today
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters